Previous Close | 55.50 |
Open | 55.00 |
Bid | 55.00 x N/A |
Ask | 56.50 x N/A |
Day's Range | 55.00 - 55.00 |
52 Week Range | 39.20 - 59.00 |
Volume | |
Avg. Volume | 3 |
Market Cap | 2.992B |
Beta (5Y Monthly) | 0.93 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LONDON, May 01, 2024--LivaNova PLC reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance.
LONDON, April 30, 2024--LivaNova PLC announced that Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer, effective May 13, 2024.
LONDON, April 25, 2024--LivaNova's wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident in late 2023.